Arbutus Biopharma

2 followers


Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).

Industries

Headquarters

Stage

Employees

Links

Org chart

Elizabeth Howard
EVP, General Counsel & Chief Compliance Officer
Michael J. Sofia Phd
Chief Scientific Officer
Karen Sims
Chief Medical Officer
Catherine Coffey Ross
Vice President Commercial Development
Michael Child
Vice President Clinical Operations
Shannon Briscoe
Vice President Human Resources
Ganapati Reddy Pamulapati
Senior Vice President, Pharmaceutical Development And Manufacturing